Calton & Associates’s Chemours CC Stock Holding History

Calton & Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,361	Closed	-$261K	–	308
2018 Q1	$261K	Buy	5,361 +622	+13%	+$31.1K	0.08%	265
2017 Q4	$254K	Buy	+4,739	New	+$248K	0.06%	284

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Calton & Associates's CC Position: Q2 2018 in Review

Calton & Associates sold out of Chemours (CC) in Q2 2018, closing a stake of 5,361 shares — an estimated $261K sold.

Calton & Associates first reported a position in CC in Q4 2017 and held it in 2 quarters. The position peaked at $261K in Q1 2018. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

Calton & Associates reported no remaining Chemours position as of Q2 2018 after selling out during the quarter.
Calton & Associates sold 5,361 Chemours shares in Q2 2018, an estimated $261K.
Calton & Associates first reported a position in Chemours in Q4 2017 and held it in 2 quarters.
Calton & Associates's Chemours position peaked at $261K in Q1 2018.
558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on Calton & Associates's 13F filing for Q2 2018, filed 10 Aug 2018.